General
Knowledge
MOA
Drug Interactions
Warning & Precautions
Hyperuricemia
Warning & Precautions
Tendon Rupture
100

In the Nexlizet Study 053, name the percentage of patients on a statin therapy

What is 65%

100

The inhibition of this by bempedoic acid causes upregulation of LDL-C receptors, which leads to increased clearance of LDL-C in the blood.

What is ATP citrate lyase

100

In the bempedoic acid package insert, lab tests did what upon discontinuation of treatment

What is return to baseline

100

Elevated uric acid levels can lead to this disease in the body

What is gout

100

This is what you should do at first sign of a tendon rupture

What is discontinue treatment

200

In the Nexlizet Study 053, this was the median LDL-C at baseline

What is 149.7

200

This type of treatment MOA involves the inhibition of HMG-CoA reductase and therefore reduces the conversion of HMG-CoA to mevalonate

What is a statin

200
In the bempedoic acid package insert, bempedoic acid was associated with persistent changes in multiple lab test within how many weeks of treatment

What is 4 weeks of treatment

200
This is the usual timeframe where someone will see uric acid elevations after initiation of bempedoic acid

What is first four weeks of treament

200

In clinical trials, this is the percentage of patients treated with bempedoic acid that experienced a tendon rupture

What is 0.5%

300

In the Nexlizet Study 053, the exclusion criteria for patients enrolled in the study was the following:

What is patients on simvastatin 40 mg or higher, fibrates, niacin, bile acid sequestrants, ezetimibe and PCSK9 inhibitors.

300

This type of treatment MOA involves the sterol transporter Neimann-Pick C1 Like 1 (NPC1L1)

What is ezetimibe

300
In the bempedoic acid package insert, patients on bempedoic acid saw decreases in these two lab tests

What is hemoglobin and leukocytes

300

This is the transporter that bempedoic acid inhibits that may lead to increased blood uric acid levels

What is Renal Tubular Organic Anion transporter 2 (OAT2)

300

This is the timeline that you may see tendon rupture once initiating bempedoic acid.

What are weeks to months of starting?

400

In the bempedoic acid package insert, there are two drug interactions to be concerned with. Provide the names and how to avoid any potential interactions

What is simvastatin > 20 mg and pravastatin > 40 mg. Avoid use.

400

This product reduces elevated LDL-C through inhibition of cholesterol synthesis in the liver and absorption in the intestine.

What is Nexlizet

400

In the bempedoic acid package insert, some patients experienced increases in hepatic transaminases. IN most cases these elevations were...

What is transient and resolved or improved with continued therapy or after discontinuation of therapy

400

This is the percentage of patients treated with bempedoic acid that experienced gout in the package insert

What is 1.5%

400

These areas of the body are involved in the tendon rupture warning in the bempedoic acid package insert

What are rotator cuff, biceps tendon and Achilles tendon

500

Name the 5 drug interactions outlined in the Nexlizet package insert

What is Simvastatin (avoid >20 mg), pravastatin (avoid >40 mg), cyclosporin (monitor), fibrates (don't use except fenofibrate) and cholestyramine (administer Nexlizet either at least 2 hours before or at least 4 hours after bile acid sequestrants.)

500

This enzyme activates bempedoic acid in the liver to reduce the biosynthesis  of cholesterol, upregulate LDL receptors and increase the clearance of LDL-c

What is ACSVL1

500

In the bempedoic acid package insert, patients on bempedoic acid saw increases in various lab tests. Name at least 3.

What is creatine and blood urea nitrogen, platelet counts, liver enzymes and creatine kinase

500

This is the percentage of patients treated with bempedoic acid vs placebo that had no prior history of gout that ended up with gout.

What is 1% bempedoic acid group vs 0.3% placebo

500

Tendon ruptures have been determined to occur more frequently in these patient situations

What are patients > 60 years of age, those taking a corticosteroid or flourquinolone, patients in renal failure and in patients with previous tendon ruptures